Navigation Links
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
Date:8/7/2009

. He served as product leader for that company's lead cancer compound to treat prostate and breast cancer.

"Metabolic disruption technology holds tremendous hope for patients with drug resistant tumors," said Haig Keledjian, CEO of Viral Genetics. "Dr. Trauger has worked in the biotech industry for 20 years and for the last 15 years has focused exclusively on bringing new cancer therapies to the clinic. We believe that he has the knowledge and experience to take this program forward. Creating a new corporation dedicated to that effort is critical to give this science the attention it deserves. At the same time, it enables Viral Genetics to remain focused on its core mission of pursuing treatments for autoimmune diseases, in addition to our primary focus of HIV and AIDS."

Viral Genetics has an option to acquire exclusive rights to the metabolic disruption technology from the University of Vermont and the University of Colorado, where the technology was invented and developed by Dr. Newell. Viral Genetics is completing negotiations to convert the option into an exclusive worldwide license covering a broad range of uses and specific therapeutic compositions.

Upon completion of certain benchmarks, Dr. Trauger will have the opportunity to acquire a 25% stake in the new company.

Viral Genetics has taken additional steps to strengthen its place in the marketplace by filing an unaudited financial statement at www.PinkSheets.com. That statement covers the company's financials for the last 18-months through March 31, 2009. Viral Genetics also recently retired a significant portion of its debt, enabling the majority of any new funding to go directly to bringing new drugs to the marketplace.

ABOUT VIRAL GENETICS:

Headquartered in San Marino, California, Viral Genetics discovers and develops
'/>"/>

SOURCE Viral Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances
2. Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website
3. New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance
4. BIO Visitors Bring Viral Preparedness to Atlanta
5. Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA
6. INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients
7. Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray
8. Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123
9. Researchers decode viral process that prepares cells for HIV infection
10. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
11. World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...-TwomoreprestigiousuniversitieshavejoinedBioCareer...iteforlifescienceprofessionals. ,, Northwestern...ining28othermajorlifesciencetrainingInstitutions. ...forpost-graduatesinthelifesciences.Whiletherearehu...eerCenteristheonlyonethatserveslifesciencepost-gra...
(Date:11/24/2009)...ire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN ...ionsbytheU.S.BankruptcyCourtfortheDistrictofDelawa...ntarypetitionfor,reliefunderChapter11oftheUnitedSt...TheordersissuedbytheBankruptcyCourtallowthecompany...roceedings.Inparticular,the,companyreceivedinterim...
(Date:11/24/2009)...pproved the Promega PowerPlex 16 HS System for use...A records for the National DNA Index System. , ...he FBI recently approved the Promega PowerPlex&re...ting in, or generating DNA records for, the Nation...s more than seven million profiles and has assiste...
(Date:11/24/2009)...-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )toda...hairman,willpresentatthe21stAnnualPiperJaffrayHeal...009at10:00a.m.ET. ,, Toaccesstheliveandsubseque...torRelationssectionofGenomicHealth,swebsiteat http...ebsiteatleast15minutespriortothebeginningofthepres...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2
..., Calif., May 28 CV Therapeutics,Inc. (Nasdaq: C...daq,marketplace rule 4350, the Company issued new ...ers due to additional hiring, primarily in connect...ed States., The inducement stock options cover an...classified as non-qualified stock options with an,...
...Genmab Reports Results for the First Three Months ...N),announced today results for the three month per...ab reported the following results:, Genmab,s reve... for the,first quarter of 2008. In the same period...lion (approx. USD 17 million)., An operating loss...
...hio, May 28 The automation of,transaction-based p...alth,plans in the United States. Foresight Corpora...mber and scale of installations of Transaction,Ins...n automation., Transaction automation techniques ... costs significantly by integrating validation, er...
Other Biology Technology:CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 2Genmab Announces 2008 First Quarter Results 2Genmab Announces 2008 First Quarter Results 3Genmab Announces 2008 First Quarter Results 4New Trend Sweeping Nation's Health Plans: Transaction Automation 2
(Date:11/23/2009)...urrent research suggests that a common oral bacter...d report by Nichols et al, "Unique Lipids from a C...2 Ligands Capable of Enhancing Autoimmunity," appe...urnal of Pathology . , Multiple sclerosis (MS), ...n and spinal cord, affects nearly 1 in 700 people ...
(Date:11/23/2009)... - By producing some of the highest resolution ima...entists have a deeper understanding how biomolecul...ay lead to a new treatment for kidney stones using...the Nov. 23 online edition of the journal Proceed...s how peptides interact with mineral surfaces by a...
(Date:11/23/2009)...niversity of New Hampshire microbiologist Louis Ti...vance understanding of the actinorhizal plants, wi...rient-poor and contaminated soils. , The United...isa, a professor of molecular, cellular and biomed...elationship between the bacteria Frankia and Casua...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3UNH prof. receives nearly $500,000 to research environmentally significant plants 2Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 1Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 2Scientists Reverse Multiple Sclerosis in Mice 54342 1Scientists Reverse Multiple Sclerosis in Mice 54342 2Human mind 3A Sound and vision wired through same black box 54340 1Human mind 3A Sound and vision wired through same black box 54340 2
...ies are repairing the human body in ways never ima...n increasing population of patients who are newly ...nd chronic fungal infections have become a formida... Aspergillus fumigatus , the focus of a new text f... engineered to offer the latest insights into the ...
...le in Spanish . , , The conditioning Works of S...unt of vegetable species. The researchers of the ...d to grow in the laboratory two native bushy speci...e cover restoration. They will try to use them to ... Sierra Nevada . , The vegetable species of Sierr...
...ke Salmonella typhimurium employ a startling arr...efense mechanisms and produce illness. Through th...ocks of cellular physiologysuch microbes ingenious...isease-causing potential or virulence. , Althou...ce factors is now well advanced, many pieces of th...
Other Biology News:New text focuses on formidable opportunistic fungus 2An essay proves that vegetation could recover in the ski resort of Sierra Nevada 2The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 2The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 3The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 4The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 5
...throughput protein crystallography involves using ...ut Screening (HTS). The liquid handling requiremen...itional crystallography plates have 24 or 48 wells...her throughput, the number of wells has increased ...
...everse-iT™ One-Step Kit is the ultimate in co...CR. It has been specifically designed to streamlin...ep Kit combines the unique Reverse-iT™ Blend ...olymerase to provide a highly sensitive, reproduci...
...nogen: Synthetic Peptide: M(1) E F L P E P Q H P ...racting protein 3 (Mint3) from mouse cells.,P...procedures. By Western blot, this antibody detect... cell extract.,PA1-072 immunizing peptide cor...
Custom LNA Oligonucleotide synthesis from Exiqon
Biology Products: